Contribution: Industrial Research Assistance Program – Contributions to Firms
Axolotl Biosciences Inc.
$25,000.00
Research and Development of HeartPrint bioink
EF 2021-22 · 2021-11-01
Résumé
3D bioprinting enables the generation of human tissue models for screening potential drug targets in a more relevant fashion compared to animal models. This project is to perform the market research on what would be desirable features for the bioink capable of printing human cardiac tissues along with the initial R&D for this product.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Victoria|Victoria, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
740149539
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2021-11-01 | 2021-22 | $50,000.00 |
| 1 | 2021-11-01 | 2021-22 | $25,000.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The total amended value is -25,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de - 25 000 dollars.
Agreement End Date
2022-04-30
Agreement Number
981586
Agreement Start Date
2021-11-01
Agreement Title
Research and Development of HeartPrint bioink
Agreement Title (French)
Recherche et développement de l'encre biologique HeartPrint
Agreement Type
Contribution
Agreement Value
$25,000.00
Amendment Date
2022-03-21
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
3D bioprinting enables the generation of human tissue models for screening potential drug targets in a more relevant fashion compared to animal models. This project is to perform the market research on what would be desirable features for the bioink capable of printing human cardiac tissues along with the initial R&D for this product.
Description (French)
La bio-impression 3D permet de générer des modèles de tissus humains pour le dépistage de cibles médicamenteuses potentielles de manière plus pertinente que les modèles animaux. Ce projet vise à réaliser une étude de marché sur les caractéristiques souhaitables d'une encre biologique capable d'imprimer des tissus cardiaques humains, ainsi que la R-D initiale de ce produit.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Victoria
Federal Riding (French)
Victoria
Federal Riding Number
59041
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
740149539
Recipient City
Victoria|Victoria
Recipient Country
CA
Recipient Legal Name
Axolotl Biosciences Inc.
Recipient Postal Code
V8W 2Y2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2021-2022-Q3-981586
